Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-08-13Clinical Trial Update: Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
A clinical trial update comparing presentation and treatment response between never-smokers and smokers with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients [NA]
A completed clinical trial evaluated the impact of exercise training on angiogenesis and cachexia in patients with non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating a combination of paclitaxel, carboplatin, and gefitinib in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating gemcitabine and cisplatin given before or after surgery in patients with stage I or…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial assessing whether blood and tissue biomarkers can predict response to second-line therapy with erlotinib hydrochloride or chem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating Paclitaxel and Carboplatin with or without nitroglycerin for previously untreated stage III or stag…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating mapatumumab in combination with paclitaxel and carboplatin in pati…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating optimization of radiotherapy plus chemotherapy for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 3]
This document provides a Phase 3 trial update on combination chemotherapy for stage IIIB or stage IV non-small cell lung cancer; the current…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of TRM-1, a TRAIL-R1 monoclonal antibody, in relapsed or refractory non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 3]
This Phase 3 trial evaluated cisplatin plus vinorelbine with or without tirapazamine in patients with stage IIIB or stage IV non-small cell …
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating whether preventive brain radiation therapy reduces brain metastases compared with observation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial in advanced non-small cell lung cancer evaluating hydroxychloroquine with or without erlotinib was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). [Phase 3]
A Phase 3, placebo-controlled trial of sorafenib in predominantly non-squamous non-small cell lung cancer after third or fourth line therapy…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy followed by surgery for patients with stage IIIA non-small cell lung cancer has…
-
CLINICAL_TRIALS withdrawal · 2013-07-25Clinical Trial Update: A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation [Phase 1, Phase 2]
A Phase I/II trial of tivozanib and erlotinib for metastatic non-small cell lung cancer, assigned by VeriStrat serum proteomic evaluation, h…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating figitumumab (CP-751,871) with erlotinib in refractory lung cancer was terminated and results were …
-
CLINICAL_TRIALS withdrawal · 2013-07-23Clinical Trial Update: 64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab [NA]
The clinical trial evaluating 64CuATSM and hypoxia in stage IV non-small cell lung cancer using carboplatin, paclitaxel, and bevacizumab has…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab with or without erlotinib hydrochloride for non-small cell lung cancer in …
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating apricoxib or placebo with docetaxel or pemetrexed in non-small cell lung cancer has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ro 50-3821 to treat anemia in patients with stage IIIB or IV non-small cell lung cancer receiving antine…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]
A Phase 1 study evaluated intravenous interleukin-4 PE38KDEL cytotoxin in patients with recurrent or metastatic breast cancer, renal cell ca…
-
CLINICAL_TRIALS research · 2013-07-18Clinical Trial Update: Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy
This clinical trial update describes a study combining preconditioning chemotherapy with cytokine-induced killer (CIK) cell immunotherapy fo…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A phase 2 trial of temsirolimus (CCI-779) for stage IIIB (with pleural effusion) or stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy [Phase 2]
Phase 2 study evaluating the combination of carboplatin, gemcitabine, and bevacizumab in locally advanced or metastatic non-small cell lung …